Page 127 - Biomedical Engineering and Design Handbook Volume 2, Applications
P. 127

106  MEDICAL DEVICE DESIGN

                       Mitrani, R. D., J. D. Simmons, et al. (1999). “Cardiac pacemakers: current and future status.” Curr Probl Cardiol,
                         24(6):341–420.
                       Moller, M. and P. Arnsbo (1996). “Appraisal of pacing lead performance from the Danish Pacemaker Register.”
                         Pacing Clin Electrophysiol, 19(9):1327–36.
                       Mond, H. G., M. Irwin, et al. (2004). “The world survey of cardiac pacing and cardioverter defibrillators: calen-
                         dar year 2001.” Pacing Clin Electrophysiol, 27(7):955–64.
                       Montoya, J. P., C. J. Shanley, et al. (1992). “Plasma leakage through microporous membranes. Role of phospho-
                         lipids.” ASAIO J, 38(3):M399–405.
                       Morice, M. C., P. W. Serruys, et al. (2002). “A randomized comparison of a sirolimus-eluting stent with a stan-
                         dard stent for coronary revascularization.” N Engl J Med, 346(23):1773–80.
                       Morley-Davies, A. and S. M. Cobbe (1997). “Cardiac pacing.” Lancet, 349(9044):41–6.
                       Morris, M. M., B. H. KenKnight, et al. (1999). “A preview of implantable cardioverter defibrillator systems in
                         the next millennium: an integrative cardiac rhythm management approach.” Am J Cardiol, 83(5B):48D–54D.
                       Moses, J. W., M. B. Leon, et al. (2003). “Sirolimus-eluting stents versus standard stents in patients with stenosis
                         in a native coronary artery.” N Engl J Med, 349(14):1315–23.
                       Mottaghy, K., B. Oedekoven, et al. (1989). “Technical aspects of plasma leakage prevention in microporous cap-
                         illary membrane oxygenators.” ASAIO Trans, 35(3):640–3.
                       Mueller, X. M., H. T. Tevaearai, et al. (1999). “Thrombogenicity of deflated intraaortic balloon: impact of heparin
                         coating.” Artif Organs, 23(2):195–8.
                       Namyslowski, J. and N. H. Patel (1999). “Central venous access: A new task for interventional radiologists.”
                         Cardiovasc Intervent Radiol, 22(5):355–68.
                       Nield, T. A., D. Langenbacher, et al. (2000). “Neurodevelopmental outcome at 3.5 years of age in children treated
                         with extracorporeal life support: relationship to primary diagnosis.” J Pediatr, 136(3):338–44.
                       Niklason, L. E., J. Gao, et al. (1999). “Functional arteries grown in vitro.” Science, 284(5413):489–93.
                       Norgren, L., W. R. Hiatt, et al. (2007). “Inter-Society Consensus for the Management of Peripheral Arterial
                         Disease (TASC II).” J Vasc Surg 45(Suppl S):S5–67.
                       O’Grady, N. P., M. Alexander, et al (2002). “Guidelines for the Prevention of Intravascular Catheter-Related
                         Infections.” Clin Infect Dis, 35(11):1281–1307.
                       Oesterle, S. N., R. Whitbourn, et al. (1998). “The stent decade: 1987 to 1997. Stanford Stent Summit faculty.”
                         Am Heart J, 136(4 Pt 1):578–99.
                       Okabe, T., Y. Asakura, et al. (1999). “Evaluation of scaffolding effects of five different types of stents by intravas-
                         cular ultrasound analysis.” Am J Cardiol, 84(9):981–6.
                       Ovrum, E., G. Tangen, et al. (2003). “Heparin-coated circuits (Duraflo II) with reduced versus full anticoagula-
                         tion during coronary artery bypass surgery.” J Card Surg, 18(2):140–6.
                       Owings, M. F. and L. Lawrence (1999). “Detailed diagnoses and procedures, National Hospital Discharge
                         Survey, 1997.” Vital Health Stat, 13(145):1–157.
                       Palder, S. B., R. L. Kirkman, et al. (1985). “Vascular access for hemodialysis. Patency rates and results of revision.”
                         Ann Surg, 202(2):235–9.
                       Park, P. K., B. E. Jarrell, et al. (1990). “Thrombus-free, human endothelial surface in the midregion of a Dacron
                         vascular graft in the splanchnic venous circuit—observations after nine months of implantation.” J Vasc Surg,
                         11(3):468–75.
                       Pasquinelli, G., A. Freyrie, et al. (1990). “Healing of prosthetic arterial grafts.” Scanning Micros, 4(2):351–62.
                       Pearson, M. L. (1996). “Guideline for prevention of intravascular device-related infections. Part I. Intravascular
                         device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee.” Am J
                         Infect Control, 24(4):262–77.
                       Peek, G. J., F. Clemens, et al. (2006). “CESAR: conventional ventilatory support vs extracorporeal membrane
                         oxygenation for severe adult respiratory failure.” BMC Health Serv Res, 6:163.
                       Pertosa, G., G. Grandaliano, et al. (2000). “Clinical relevance of cytokine production in hemodialysis.” Kidney
                         Int, 58(Suppl 76):Sl04–11.
                       Pinski, S. L. and R. G.  Trohman (2000). “Permanent pacing via implantable defibrillators.”  Pacing Clin
                         Electrophysiol, 23(11 Pt l):1667–82.
                       Raad, I. (1998). “Intravascular-catheter-related infections.” Lancet, 351 (9106):893–8.
   122   123   124   125   126   127   128   129   130   131   132